PIEZO1 and metabolic disease: However, under pathological conditions like OA, dysfunction of Piezo1 may lead to metabolic disorders in chondrocytes (Lee W. et al., 2021), accelerating cartilage degradation (Gan et al., 2024) and joint dysfunction (Liu Y. et al., 2023).